Involvement of CD70-CD27 interactions in the induction of experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 109, Issue 2, 2000, Pages 188-196

  Nakajima, Atsuo ^a,b   Oshima, Hideo ^b,c   Nohara, Chiyoko ^b   Morimoto, Shinji ^b   Yoshino, Shin ichi ^a   Kobata, Tetsuji ^b   Yagita, Hideo ^b,d   Okumura, Ko ^b,d  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Autoimmunity; Co stimulatory molecules; Cytokine; EAE

Indexed keywords

CD27 ANTIGEN; CD70 ANTIGEN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL INTERACTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENCEPHALOMYELITIS; FEMALE; IMMUNIZATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMAL; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD27; ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE; FEMALE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, INBRED STRAINS; MYELIN PROTEOLIPID PROTEIN; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; SUPPORT, NON-U.S. GOV'T; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR;

EID: 0034703189     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00324-6     Document Type: Article

References (55)

1. Agematsu K., Kobata T., Sugita K., Freeman G.J., Beckmann M.P., Schlossman S.F., Morimoto C. Role of CD27 in T cell immune response. Analysis by recombinant soluble CD27. J. Immunol. 153:1994;1421-1429.
2. + B cells and helper T cells in immunoglobulin production. Eur. J. Immunol. 27:1997;2073-2079.
3. + T lymphocytes. J. Immunol. 154:1995;3686-3695.
4. Brugnoni D., Airo P., Marino R., Notarangelo L.D., van Lier R.A., Cattaneo R. CD70 expression on T-cell subpopulations: study of normal individuals and patients with chronic immune activation. Immunol. Lett. 55:(2):1997;99-104.
5. + T lymphocytes by 4-1BB ligand. J. Immunol. 158:1997;551-559.
6. Ding L., Shevach E.M. Activated B cells express CD28/B7-independent costimulatory activity. J. Immunol. 157:1996;1389-1396.
7. Frei K., Eugster H.-P., Bopst M., Constantinescu C.S., Lavi E., Fontana A. Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1997;2177-2182.
8. Goodwin R.G., Alderson M.R., Smith C.A., Armitage R.J., VandenBos T., Jerzy R., Tough T.W., Schoenborn M.A., Davis-Smith T., Hennen K.E.A. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell. 73:1993;447-456.
9. Gravestein L.A., Nieland J.D., Knuisbeek A.M., Borst J. Novel mAbs reveal potent co-stimulatory activity of murine CD27. Int. Immunol. 7:1995;551-557.
10. Grewal I., Flavell R.A. The role of CD40 ligand in costimulation and T-cell activation. Immunol. Rev. 153:1996;87-106.
11. + T-cell response. Immunol. Today. 17:1996;410-414.
12. Hintzen R.Q., de Jong R., Lens S.M., van Lier R.A. CD27: marker and mediator of T-cell activation? Immunol. Today. 15:1994;307-311.
13. Hintzen R.Q., Lens S.M., Lammers K., Kuiper H., Beckmann M.P., van Lier R.A. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J. Immunol. 154:1995;2612-2623.
14. Hjelmstrom P., Juedes A.E., Fjell J., Ruddle N.H. B cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol. 161:1998;4480-4483.
15. Hohlfelt R., Londei M., Massacesi L., Salvetti M. T-cell autoimmunity in multiple sclerosis. Immunol. Today. 16:1995;259-261.
16. Hurtade J.C., Kim S.H., Pollok K.E., Lee Z.H., Kwon B.S. Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28. J. Immunol. 155:1995;3360-3367.
17. Jacquot S., Kobata T., Iwata S., Morimoto C., Schlossman S.F. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling. J. Immunol. 159:1997;2652-2657.
18. June C.H., Bluestone J.A., Nadler L.M., Thompson C.B. The B7 and CD28 receptor families. Immunol. Today. 15:1994;321-331.
19. Khoury S.J., Akalin E., Chandraker A., Turka L.A., Linsley P.S., Sayegh M.H., Hancock W.W. CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spare Th2 cytokines in the central nervous system. J. Immunol. 155:1995;4521-4524.
20. + naive T cell costimulation. J. Immunol. 153:1994;5422-5432.
21. Kobata T., Jacquot S., Kozlowski S., Agematsu K., Schlossman S.F., Morimoto C. CD27-CD70 interactions regulate B-cell activation by T cells. Proc. Natl. Acad. Sci. USA. 92:1995;11249-11253.
22. Korner H., Riminton D.S., Strickland D.H., Lemckert F.A., Pollard J.D., Sedgwick J.D. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med. 186:1994;1585-1590.
23. Kuchroo V.K., Prabhu Das M., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nabavi N., Glimcher L.H. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80:1995;707-718.
24. Lens S.M.A., Tesselaar K., van Oers M.H.J., van Lier R.A.W. Control of lymphocyte function through CD27-CD70 interactions. Semin. Immunol. 10:1998;491-499.
25. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:1996;233-258.
26. Liu J., Marino M.W., Wong G., Grail D., Dunn A., Bettadapura J., Slavin A.J., Old L., Brenard C.A. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 4:1998;78-83.
27. Lynch D.H., Ramsdell F., Alderson M.R. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today. 16:1995;569-574.
28. Lyons J.-A., San M., Happ M.P., Cross A.H. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29:1999;3432-3439.
29. Matsumoto Y., Kohyama K., Aikawa Y., Shin T., Kawazoe Y., Suzuki Y., Tanuma N. Role of natural killer cells and TCRγδ T cells in acute autoimmune encephalomyelitis. Eur. J. Immunol. 28:1998;1681-1688.
30. Mauri C., Williams R.O., Walmsley M., Feldmann M. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur. J. Immunol. 26:1996;1511-1518.
31. Miller S.D., Karpus W.J. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol. Today. 15:1994;356-361.
32. Miossec P., Van Den Berg W. Th1/Th2 cytokine balance in arthritis. Arthritis Rheum. 40:1997;2105-2115.
33. Mueller D.L., Jenkins M.K., Schwartz R.H. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:1989;445-480.
34. Myers K.J., Sprent J., Dougherty J.P., Ron Y. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 41:1992;1-8.
35. Nakajima A., Azuma M., Kodera S., Nuriya S., Terashi A., Hirose S., Shirai T., Yagita H., Okumura K. Preferential dependence of autoantibody production in murine lupus on CD86 co-stimulatory molecule. Eur. J. Immunol. 25:1995;3060-3069.
36. Nakajima A., Hirose S., Yagita H., Okumura K. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. J. Immunol. 158:1997;1466-1472.
37. Navikas V., Link H. Cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 45:1996;322-333.
38. O'Doherty U., Steinman R.M., Peng M., Cameron P.U., Gezelter S., Kopeloff I., Swiggard W.J., Pope M., Bhardwaj N. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J. Exp. Med. 178:1993;1067-1078.
39. Oshima H., Nakano H., Nohara C., Kobata T., Nakajima A., Jenkins N.A., Gilbert D.J., Copelamd N.G., Muto T., Yagita H., Okumura K. Characterization of murine CD70 by molecular cloning and mAb. Int. Immunol. 10:1998;517-526.
40. Raine C.S. A review of the oligodendrocyte in the multiple sclerosis lesion. J. Neuroimmunol. 77:1997;135-152.
41. Ruddle N.H., Bergman C.M., McGrath K.M., Lingenheld E.G., Grunnet M.L., Padula S.J., Clark R.B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1990;1193-1200.
42. Schwartz R.H. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell. 71:1992;1065-1068.
43. Selmaj K., Raine C.S., Cross A.H. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30:1991;694-700.
44. Shahinian A., Pfeffer K., Lee K.P., Kundig T.M., Kishihara K., Wakeham A., Kawai K., Ohashi P.S., Thompson C.B., Mak T.W. Differential T cell costimulatory requirements in CD28-deficient mice. Science. 261:1993;609-612.
45. Smith C.A., Farrah T., Goodwin R.G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and cell death. Cell. 76:1994;959-962.
46. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 85:1996;299-302.
47. Steinman L. Some misconceptions about understanding autoimmunity through experiments with knockouts. J. Exp. Med. 185:1997;2039-2041.
48. Stuhler G., Zobywalski A., Grunebach F., Brossart P., Reichardt V.L., Barth H., Stevanovic S., Brugger W., Kanz L., Schlossman S.F. Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clusters. Proc. Natl. Acad. Sci. USA. 96:1999;1532-1535.
49. Suen W.E., Bergman C.M., Hjelmstrom P., Ruddle N.H. A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med. 186:1997;1233-1240.
50. Takeda K., Oshima H., Hayakawa Y., Akiba H., Atsuta M., Kobata T., Kobayashi K., Ito M., Yagita H., Okumura K. CD27-mediated activation of murine NK cells. J. Immunol. 164:2000;1741-1745.
51. Trembleau S., Germann T., Gately M.K., Adorini L. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today. 16:1995;383-386.
52. Willenborg D.O., Prowse S.J. Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis. J. Neuroimmunol. 5:1983;99-109.
53. Willenborg D.O., Sjollema P., Danta G. Immunoglobulin-deficient rats as donors and recipients of effector cells of allergic encephalomyelitis. J. Neuroimmunol. 11:1986;93-103.
54. Wolf S.D., Dittel B.N., Hardardottir F., Janeway C.A. Jr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184:1996;2271-2278.
55. Zhang B., Yamamura T., Kondo T., Fujisawa M., Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186:1997;1677-1687.